NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/11/2025
Voltar para busca
Dado oficial do USPTO
ZYTONOVA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ZYTONOVA
ST13
US500000079368062Classe
1, 5, 9, 10, 35, 42, 44
Pedido
79368062
Registro
7383469
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
07/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 35, 42, 44
Data de depósito
17/11/2022
Data de registro
14/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/05/2024
Última transação
07/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
MARTIN,JENNIFER MCGARRY
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ZytoVision GmbH
Representantes
Laurence P. Colton SMITH TEMPEL BLAHA LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; chemical preparations for analyses in laboratoriesother than for medical or veterinary purposes; biochemicalspolynucleotidesoligonucleotidespeptidesproteinsenzymesantibodies for in vitro scientific and research purposes; chemicals and biochemicalsnucleic acids and antibodies for use in the detection of genetic alterationsother than for medical or veterinary purposes; nucleic acids and antibodies for laboratory use; chemicals for use in industry and sciencedna probesrna probes and oligonucleotide probes being biochemical substancesantibodiesenzymesoligonucleotides for carrying out molecular biological processes; mixtures of chemical reagents in kit formother than for medical or veterinary purposeskits for scientific purposes consisting primarily of chemical reagents
Classe 5
Medical preparationsmedical diagnostic reagents for diagnosis of genetic disorders; medical preparations for diagnosticsmedical diagnostic reagents for diagnosis of genetic aberrations in tumors; medical preparations for in vitro diagnosticstest kits containing antibodiesprobesenzymesbuffers and reagents for diagnosis of genetic disorders including genetic aberrations in tumors; nucleic acids sequencespeptide sequenceschemical reagents for medical and veterinary purposes; biological and chemical preparationsdnarna and oligonucleotide probes composed of biochemical substancesoligonucleotidesproteins and enzymes and antibodiesall for medical and veterinary diagnostic purposes; biological and chemical preparations for medical and veterinary purposesdna probesrna probes and oligonucleotide probes being polynucleotidesbiochemical substancesoligonucleotidesproteins and enzymes and antibodies for diagnosis of genetic disorders including genetic aberrations in tumors; diagnostic biomarker reagents for medical purposes
Classe 9
Research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; analysis apparatusresearch laboratory analyzersfor measuringtesting and examining tissuecells and biomolecules including dnarna and proteins
Classe 10
Medical analytical apparatus for medical purposesmedical diagnostic instruments for the analysis of dnarna and proteins; automatic analyzers for medical diagnosismedical diagnostic instruments for the analysis of body fluids and tissues; genetic testing apparatus for medical purposes
Classe 35
Business management consultancy and advisory services; operation of businesses for othersnamely biotechnological and medical companies; running of a holding company performed for third partiesnamely business managementbusiness administrationproviding office functions; holding company services performed for third partiesdevelopment of marketing strategybusiness management and business management consultation; business management and organization consultation; advisory services relating to business management; business administration; providing office functions; business development servicesplanning and monitoring of business developments and organizational services for business purposes
Classe 42
Science and technology servicesresearch and design in the field of genetic analyses including analyses of genetic alterations in tumors; medical laboratory services; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical researchnamely conducting clinical trials for others; research relating to biotechnology; scientific consultancy services relating to hazardous materials management; biological analysisbiochemical analysischemical analysisscientific analysisdnarnaprotein analysis services for scientific research purposes; scientific research in the field of genetics and genetic engineering
Classe 44
Medical services; medical diagnostic servicesmedical testing for diagnostic or treatment purposes; in-vitro analysis for medical and pharmaceutical usemedical services in the field of genetic disorders including genetic aberrations in tumors; medical services using the knowledge in the field of pathologygenetic sciencehuman geneticsmolecular pathologiesmolecular biologymicrobiologybiotechnology and laboratory medicine; medical services by means of histologycytologyimmunohistologyimmunohistochemistryin situ hybridizationpcr (polymerase chain reaction)ngs (next generation sequencing)microarray hybridization (genetic chip or biochip hybridization)flow cytometry and isolation of biomolecules including DNARNA and proteins; medical counseling; pharmaceutical compounding services; pharmaceutical advice; medical and healthcare services relating to dnagenetics and genetic testing; medical pathology servicesnamely pathology diagnostic services; genetic testing for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/11/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2024
FIMP
FINAL DISPOSITION PROCESSED
08/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
14/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
27/02/2024
PUBO
PUBLISHED FOR OPPOSITION
27/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/01/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
13/12/2023
GNFR
FINAL REFUSAL E-MAILED
13/12/2023
CNFR
FINAL REFUSAL WRITTEN
13/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2023
RFNT
REFUSAL PROCESSED BY IB
17/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/09/2023
RFRR
REFUSAL PROCESSED BY MPU
25/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/09/2023
CNRT
NON-FINAL ACTION WRITTEN
06/09/2023
DOCK
ASSIGNED TO EXAMINER
30/08/2023
MAFR
APPLICATION FILING RECEIPT MAILED
26/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZYTONOVA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.